fingolimod hydrochloride has been researched along with Retinitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, L; Yan, H | 1 |
| Copland, DA; Dick, AD; Nicholson, LB; Raveney, BJ | 1 |
| Anderson, K; Brinkmann, V; Copland, DA; Dick, AD; Liu, J; Nicholson, LB; Schewitz-Bowers, LP | 1 |
| Hikita, N; Ikeda, E; Kurose, S; Mochizuki, M; Tokiwa, M | 1 |
4 other study(ies) available for fingolimod hydrochloride and Retinitis
| Article | Year |
|---|---|
FTY720 Attenuates Retinal Inflammation and Protects Blood-Retinal Barrier in Diabetic Rats.
Topics: Administration, Oral; Animals; Blood-Retinal Barrier; Blotting, Western; Diabetes Mellitus, Experimental; Disease Progression; Down-Regulation; Fingolimod Hydrochloride; Immunohistochemistry; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Lysosphingolipid; Retinitis; RNA | 2016 |
Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Treatment; Female; Fingolimod Hydrochloride; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Propylene Glycols; Random Allocation; Reference Values; Retinitis; Sensitivity and Specificity; Sphingosine; Treatment Outcome; Uveitis | 2008 |
Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier.
Topics: Animals; Apoptosis; Autoimmune Diseases; Blood-Retinal Barrier; Dose-Response Relationship, Drug; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Microvessels; Permeability; Propylene Glycols; Retinitis; Sphingosine; Uveitis | 2012 |
Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
Topics: Animals; Antibodies; Arrestin; Autoimmune Diseases; Blood Cell Count; Body Weight; Chi-Square Distribution; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Propylene Glycols; Rats; Rats, Inbred Lew; Retinitis; Sphingosine; Statistics, Nonparametric; T-Lymphocytes; Uveitis | 2000 |